STOCK TITAN

Parkervision Stock Price, News & Analysis

PRKR OTC

Welcome to our dedicated page for Parkervision news (Ticker: PRKR), a resource for investors and traders seeking the latest updates and insights on Parkervision stock.

ParkerVision, Inc. (PRKR) is a Florida-based RF technology company whose news flow is heavily shaped by intellectual property, litigation, and capital markets developments. The company describes itself as an innovator in radio-frequency (RF) technologies used in advanced wireless communication systems and as a developer and marketer of technologies and products for wireless applications. Its press releases frequently highlight how these RF technologies are protected and monetized through licensing and patent enforcement.

A major theme in ParkerVision’s news is its long-running patent litigation, particularly against Qualcomm. The company issues detailed updates on claim construction rulings, appeals to the U.S. Court of Appeals for the Federal Circuit, motions such as Rule 54(b) requests and motions to expedite, and scheduling developments in its cases. Additional coverage focuses on patent infringement actions in the Western District of Texas involving Realtek, MediaTek, Texas Instruments, and NXP Semiconductors, as well as related Patent Trial and Appeal Board (PTAB) inter partes review proceedings.

Investors following PRKR news will also see regular earnings releases and financial updates, where ParkerVision reports net losses, operating expenses, contingent payment obligations, and cash flows. The company explains how changes in the estimated fair value of contingent payment obligations and share-based compensation affect its results, and it comments on legal and consulting costs tied to its enforcement activities.

Another recurring news category involves capital-raising activity. ParkerVision has announced a shelf registration on Form S-3 and subsequent registered direct offerings of common stock under that shelf, including sales to accredited and institutional investors and to a director. These announcements outline offering terms, use of the shelf registration, and the absence of underwriters or placement agents.

For readers tracking PRKR, this news page provides a centralized view of ParkerVision’s litigation milestones, financial disclosures, and financing transactions, all of which the company presents as central to its RF intellectual property strategy.

Rhea-AI Summary

ParkerVision (OTCQB:PRKR) announced that its Supreme Court petition (No. 24-518) challenging the Federal Circuit's use of one-word affirmances in Patent Trial and Appeal Board appeals has gained significant support. The petition argues that these affirmances violate Section 144 of the Patent Act, which requires the court to issue an opinion.

Two former Federal Circuit Judges, Paul Michel and Kathleen O'Malley, have publicly supported ParkerVision's position. The case has received thirteen amici across nine briefs calling for Supreme Court review, including support from Harvard Law School's Professor Mary Ann Glendon. Notably, the respondents (TCL and LGE) did not dispute the merits of ParkerVision's petition in their opposition brief.

The Supreme Court is scheduled to consider the petition on March 21st, 2025. The outcome could significantly impact how patent appeals are handled, potentially ensuring greater transparency and accountability in the U.S. patent system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.26%
Tags
none
-
Rhea-AI Summary

ParkerVision (OTCQB:PRKR) has filed a reply brief supporting its Supreme Court petition challenging the Federal Circuit's use of Rule 36 one-word affirmances in Patent Trial and Appeal Board (PTAB) appeals. The case, No. 24-518, against TCL and LG Electronics, argues that these brief affirmances violate Section 144 of the Patent Act, which requires a detailed court opinion.

The petition has received substantial support from thirteen amici across nine briefs, including Harvard Law School's Professor Mary Ann Glendon and former Federal Circuit judges Paul Michel and Kathleen O'Malley. The case focuses on the Federal Circuit's practice of using Rule 36 to affirm PTAB patent invalidations in inter partes review (IPR) proceedings.

The respondents (TCL and LGE) did not dispute the merits of ParkerVision's petition in their opposition brief. The Supreme Court's decision could significantly impact patent appeal procedures, potentially ensuring greater transparency and accountability in the U.S. patent system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
-
Rhea-AI Summary

ParkerVision (OTCQB:PRKR) has launched 'Against the Giants,' a four-part video series focusing on its ongoing legal battle against Qualcomm. The series, available on newly created @Against_Giants social media accounts on X (formerly Twitter) and Instagram, aims to provide stakeholders with detailed insights into the litigation and its implications for intellectual property rights and fair competition in the tech industry.

CEO Jeffrey Parker stated that the series intends to present a clear narrative about protecting innovation, with hopes of scheduling a trial in 2025. The first episode is now available on social media, with subsequent episodes planned for release in the coming weeks.

ParkerVision develops and licenses advanced radio-frequency (RF) technologies for wireless communication products and is currently pursuing multiple patent enforcement actions in the U.S. to protect its technologies from alleged infringement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.25%
Tags
none
Rhea-AI Summary

ParkerVision reported Q3 2024 financial results with a net loss of $10.8 million ($0.12 per share), compared to a $3.9 million loss in Q3 2023. The increased loss primarily stems from a $9.7 million non-cash charge related to contingent payment obligations. The company received a favorable decision from the Federal Circuit Court in its patent case against Qualcomm, which has been remanded for trial. ParkerVision currently has 13 patent infringement cases against seven defendants, with four trials scheduled in Texas for 2025. The company ended Q3 with $0.8 million in cash and used $2.1 million for operations in the first nine months of 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
-
Rhea-AI Summary

ParkerVision (OTCQB:PRKR) has filed a Supreme Court petition challenging the Federal Circuit's practice of summarily affirming patent invalidations without detailed explanations. This follows the Patent Trial and Appeal Board's (PTAB) June 2024 invalidation of key ParkerVision patent claims in its dispute with TCL and LG Electronics through inter partes review. The Federal Circuit responded with a one-word 'affirmed' ruling.

The petition argues this practice violates Section 144 of the Patent Act, which requires the court to issue detailed opinions. ParkerVision contends that lack of explanations for patent invalidations creates uncertainty in the patent system and hampers innovation. The company seeks to establish a precedent requiring detailed judicial opinions for patent invalidation cases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.18%
Tags
none
-
Rhea-AI Summary

ParkerVision (OTCQB:PRKR) has won a favorable ruling from the U.S. Court of Appeals for the Federal Circuit in its patent infringement case against Qualcomm. The appellate court has:reversed the district court's exclusion of ParkerVision's expert testimony,vacated the summary judgment of non-infringement, andremanded the case back to the Middle District of Florida for trial.

This decision revives ParkerVision's decade-long legal battle, allowing the company to present its infringement claims to a jury. ParkerVision estimates that its technologies have been used without authorization in over1.5 billion Qualcomm chips. CEO Jeffrey Parker expressed optimism about swiftly bringing the case to trial, emphasizing the company's commitment to pursuing justice against Qualcomm's alleged unauthorized use of ParkerVision's proprietary technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
110.92%
Tags
none
Rhea-AI Summary

ParkerVision (OTCQB:PRKR) announced its Q2 2024 results, highlighting a net loss of $0.3 million or $0.00 per share, contrasting with a net income of $1.4 million or $0.02 per share in Q2 2023. For the first six months of 2024, the company reported a net loss of $1.0 million or $0.01 per share, versus a net income of $14.5 million or $0.17 per share in the same period of 2023, driven by a $25 million patent license and settlement agreement.

ParkerVision is actively involved in multiple legal proceedings, including awaiting a decision from the United States Court of Appeals for the Federal Circuit (CAFC) in a case against Qualcomm, following the dismissal and resubmission of an appeal in August 2024. Additionally, the company is engaged in several pending cases against Texas Instruments, NXP Semiconductors, MediaTek, and Realtek, with jury trials scheduled throughout 2025.

The company ended the quarter with $1.0 million in cash and cash equivalents, having used $1.4 million in cash for operations in the first half of 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.46%
Tags
-
Rhea-AI Summary

ParkerVision (OTCQB:PRKR), a developer of wireless communication technologies, reported a net loss of $0.7 million for Q1 2024, or $0.01 per share, contrasting with Q1 2023's net income of $13.1 million due to a $25 million patent settlement. Cash used in operations was $0.8 million, leaving the company with $1.7 million in cash. Key developments include awaiting a U.S. Court of Appeals decision on their case against Qualcomm and favorable claim rulings in patent cases against MediaTek and Realtek, with trials set for late 2024 and early 2025. Additionally, cases against various companies, including Qualcomm and Apple, remain stayed pending other outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.05%
Tags
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.81%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.71%
Tags
none

FAQ

What is the current stock price of Parkervision (PRKR)?

The current stock price of Parkervision (PRKR) is $0.22 as of April 20, 2026.

What is the market cap of Parkervision (PRKR)?

The market cap of Parkervision (PRKR) is approximately 32.5M.